| pubmed-article:16282676 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0030520 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0043668 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0249582 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:16282676 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:16282676 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16282676 | pubmed:dateCreated | 2005-12-19 | lld:pubmed |
| pubmed-article:16282676 | pubmed:abstractText | Paricalcitol and doxercalciferol are effective in reducing parathyroid hormone PTH concentrations in patients with secondary hyperparathyroidism. The purpose of this study was to determine the relative dose of doxercalciferol (compared to paricalcitol) required to maintain equivalent PTH concentrations in dialysis patients. | lld:pubmed |
| pubmed-article:16282676 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16282676 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282676 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16282676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282676 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16282676 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16282676 | pubmed:issn | 0250-8095 | lld:pubmed |
| pubmed-article:16282676 | pubmed:author | pubmed-author:SpragueStuart... | lld:pubmed |
| pubmed-article:16282676 | pubmed:author | pubmed-author:GhantousWalid... | lld:pubmed |
| pubmed-article:16282676 | pubmed:author | pubmed-author:ZismanAnna... | lld:pubmed |
| pubmed-article:16282676 | pubmed:author | pubmed-author:SchinleberPam... | lld:pubmed |
| pubmed-article:16282676 | pubmed:author | pubmed-author:RobertsLaurie... | lld:pubmed |
| pubmed-article:16282676 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16282676 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:16282676 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16282676 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16282676 | pubmed:pagination | 591-5 | lld:pubmed |
| pubmed-article:16282676 | pubmed:dateRevised | 2007-2-14 | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:meshHeading | pubmed-meshheading:16282676... | lld:pubmed |
| pubmed-article:16282676 | pubmed:articleTitle | Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol. | lld:pubmed |
| pubmed-article:16282676 | pubmed:affiliation | Evanston Northwestern Healthcare, Division of Nephrology, Northwestern University Feinberg School of Medicine, 2650 Ridge Ave, IL 60201, USA. | lld:pubmed |
| pubmed-article:16282676 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16282676 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16282676 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16282676 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16282676 | pubmed:publicationType | Clinical Trial, Phase IV | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16282676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16282676 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16282676 | lld:pubmed |
